Hemostasis and Tissue Sealing Agents Market Segmentation by Product Type (Topical Hemostats, Adhesive, and Tissue Sealant); by Material Type (Collagen Based, Gelatin Based, and Others); and by End User (Hospitals, Ambulatory Surgical Centers, and Others)-Global Demand Analysis & Opportunity Outlook 2031

  • Product Code:
    RP-ID-10082384
  • Published Date:
    21 Oct 2022
  • Region:
    Global
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-54

Impact Analysis on the Growth of Market

Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

..

..

The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.


With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.



Market Overview:

Translate Report

Global Hemostasis and Tissue Sealing Agents Market Highlights Over 2022 - 2031

The global hemostasis and tissue sealing agents market garnered revenue of approximately USD 2,700 million by the end of the year 2021. The market is anticipated to grow at a CAGR of ~7% over the forecast period, i.e., 2022– 2031. The growth of the market can be attributed to increasing injuries and accidents with people that lead to severe blood loss. Approximately 300 million surgeries are executed every year globally. Around 40 – 50 million surgeries are performed in the U.S. and 20 million in the European region. Additionally, most of the rising old age population is suffering from different chronic diseases that create a need for surgery which further raises demand for the product.

 

Hemostasis and Tissue Sealing Agents Market Growth, Trends & Industry Analysis

 

CLICK TO DOWNLOAD SAMPLE REPORT

 

Furthermore, an increase in product approvals by regulatory bodies is expected to bolster the growth of the market. These products are extensively used in the medical and healthcare service sector and are used to stop bleeding which can be done mechanically or by increasing the coagulation cascade. These devices bind and heal the defects in the tissues of the patient’s body at the bleeding spot. These agents have a wide range of suitability as these products can be used in endoscopic procedures as well as urological treatments. Medical advancements as well as research & development in the field of healthcare sector are expected to proper the market growth. However, exorbitant surgical procedures as well as insufficient reimbursements for these products are expected to hinder the growth of the market.

On the basis of product type, the market is segmented into topical hemostats, adhesive and tissue sealing agents, out of which, the topical hemostats segment is estimated to hold the largest share of the market during the forecast period owing to factors such as quick blood absorbability as well as lesser tissue reactivity. Additionally, it has fast healing properties which promote platelet activation to form clotting matrix at the bleeding spot.

Global Hemostasis and Tissue Sealing Agents Market Regional Synopsis

Regionally, the global hemostasis and tissue sealing agents market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America region is estimated to witness noteworthy growth over the forecast period on the back of factors, such as the rising number of chronic diseases that require serious surgeries. The U.S. is suffering from an epidemic where around 50% of the total population has been distressed with some kind of chronic disease. Besides these, frequent cases of injuries and accidents in the U.S. and Canada as well as active investments by key players in the medical product pipeline development are expected to contribute towards the market growth.

Market Segmentation

Our in-depth analysis of the global hemostasis and tissue sealing agents market includes the following segments: 

By Product Type 

  • Topical Hemostats 
    • Active Hemostats

    • Mechanical Hemostats

    • Flowable Hemostats

    • Fibrin Sealants

    • Topical Thrombin Products

  • Adhesive
    • Synthetic

    • Natural

    • Adhesion Barrier

  • Tissue Sealant

By Material Type

  • Collagen Based

  • Gelatin Based

  • Oxidized Regenerated Cellulose (ORC) Based

  • Polysaccharide Based

  • Others

By End-User

  • Hospitals 

  • Ambulatory Surgical Centers 

  • Home Care Settings 

  • Others

Growth Drivers and Challenges Impacting the Growth of the Global Hemostasis and Tissue Sealing Agents Market

Growth Drivers  

  • Increasing number of surgical procedures worldwide 

  • Growing medical advancements in the field of healthcare services

Challenges 

  • High price of surgeries

  • Insufficient reimbursements for these products

Key Companies Dominating the Global Hemostasis and Tissue Sealing Agents Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global hemostasis and tissue sealing agents market that are included in our report are Pfizer Inc., Zimmer Biomet., Johnson& Johnson Services, Inc., CryoLife, Inc., Baxter International, Inc., Medtronic plc, B. Braun Melsungen AG, Integra LifeSciences, Stryker, Advanced Medical Solutions Group plc, and others.

Latest Developments in the Global Hemostasis and Tissue Sealing Agents Market:

  • July 2021: Baxter International, Inc., a leading manufacturer of medical devices proclaimed the acquisition of CryoLife, Inc.’s assets related to PerClot Polysaccharide Hemostatic System. This acquisition is aimed at strengthening the company’s portfolio and is expected to produce high-profit margins.

  • November 2020: Advanced Medical Solutions Group plc has acquired Raleigh Adhesive Coatings Limited, wound care, and biotechnology company that dealt in tissue sealing agents devices. This acquisition by the company is aimed at enhanced earnings as well as working towards commercial market opportunities. It will also help in better research and development in the arena of healthcare-related products and devices.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments. 

  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact the market growth. 

  • The report includes detailed company profiles of the major players dominating the market. 

  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth. 

  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal. 


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.

FREQUENTLY ASKED QUESTIONS

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
  1. Pfizer Inc.
  2. Zimmer Biomet.
  3. Johnson& Johnson Services Inc.
  4. CryoLife Inc.
  5. Baxter International Inc.
  6. Medtronic plc
  7. B. Braun Melsungen AG
  8. Integra LifeSciences
  9. Stryker
  10. Advanced Medical Solutions Group plc
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports

-->